Dr Grant Boyle
Dr. Grant Boyle received his BSc and BSc (Hons.) degrees from the then University of Natal.
He continued with MSc and PhD degrees at the same institution which had been renamed the University of KwaZulu-Natal. These studies were carried out in the field of asymmetric catalysis under the supervision of Prof. H. G. Kruger.
After completing his studies, Grant took up a position at iThemba Pharmaceuticals (Pty) Ltd. in June 2009. There he worked on various in-house and externally funded medchem programs in disease areas including HIV, Malaria and TB. Grant was later involved in contract medicinal chemistry work in collaboration with the Drugs for Neglected Diseases Initiative (DNDi) in disease areas such as Leishmaniasis and Trypanosomiasis.
Grant joined H3D in November 2014 and has worked on various medicinal chemistry programs within the organization in TB, Malaria and most recently the AMR disease areas. He currently leads the medicinal chemistry efforts under the J&J Center for Global Health collaboration in AMR between H3D and J&J.
In addition to his work on the medicinal chemistry programs, he leads the ongoing efforts to implement and optimise the Dotmatics ELN and Database solutions at H3D.
Grant has authored/co-authored several peer reviewed journal articles and is named as co-inventor on one patent. He was awarded the SASOL Postgraduate Medal in 2009 for his PhD work.